SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
HK Stock Market Move | SMOORE INTL(06969) rises by over 4% now. The company has signed a long-term purchase agreement with Eve Energy Co., Ltd. to ensure the supply of battery cores for electronic cigarette products.
Wanlian Securities: The fundamental operations of highways are stable, with potential policy benefits expected.
HK Stock Market Move | YOFC (06869) rose nearly 7% as Google's TPU chip sparked attention; institutions are optimistic about AI driving growth in the communication sector.
HK Stock Market Move | SMOORE INTL(06969) rises by over 4% now. The company has signed a long-term purchase agreement with Eve Energy Co., Ltd. to ensure the supply of battery cores for electronic cigarette products.
Wanlian Securities: The fundamental operations of highways are stable, with potential policy benefits expected.
HK Stock Market Move | YOFC (06869) rose nearly 7% as Google's TPU chip sparked attention; institutions are optimistic about AI driving growth in the communication sector.
RECOMMEND
Foreign Brands “Take On Chinese Names”: Starbucks And Burger King Change Hands As Chinese Capital’s Localization Scalpel Rewrites Global Rules
25/11/2025
Riding The Momentum Of Gemini 3, “Google Chain” Challenges “Nvidia Chain,” Reshaping The Ai Trading Landscape
25/11/2025
Silver Economy Accelerates As Personal Pension System Marks Three Years — Structural Changes Emerging
25/11/2025
